Literature DB >> 8951020

Cytotoxicity of phenol to musculoskeletal tumours.

U Quint1, U Vanhöfer, A Harstrick, R T Müller.   

Abstract

Local treatment with phenol is often used after intralesional excision of chondroblastomas and giant-cell tumours which involve bone near joints, and has been shown to reduce the rate of recurrence. The ideal concentration of phenol is uncertain, but may be important because of the high rate of absorption and toxicity. We have studied the effectiveness of different concentrations on standard sarcoma cell lines. Our results suggest that a 5% solution of phenol is effective against dispersed single cells, and that higher concentrations give no significant advantage, but create problems due to lack of homogeneous mixing, temperature and safety.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951020     DOI: 10.1302/0301-620x78b6.1281

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  5 in total

1.  Ethanol as a local adjuvant for giant cell tumor of bone.

Authors:  Kevin B Jones; Barry R DeYoung; Jose A Morcuende; Joseph A Buckwalter
Journal:  Iowa Orthop J       Date:  2006

2.  Giant cell tumor of bone: risk factors for recurrence.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-08-13       Impact factor: 4.176

3.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

4.  High-Speed Burring with and without the Use of Surgical Adjuvants in the Intralesional Management of Giant Cell Tumor of Bone: A Systematic Review and Meta-Analysis.

Authors:  H Algawahmed; Robert Turcotte; F Farrokhyar; M Ghert
Journal:  Sarcoma       Date:  2010-07-27

5.  Cytotoxic effect and tissue penetration of phenol for adjuvant treatment of giant cell tumours.

Authors:  Falk Mittag; Carmen Leichtle; Ina Kieckbusch; Hartwig Wolburg; Maximilian Rudert; Torsten Kluba; Ulf Leichtle
Journal:  Oncol Lett       Date:  2013-03-11       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.